Company Summary

Gilead Biopharmaceutics Ireland UC was set up on Monday the 13th of December 1999. Their current address is 70 Sir John Rogerson's Quay,Dublin 2, and the company status is Normal. The company's current directors Regan Glen Shea, Brett Alan Pletcher, Robin Washington, David Richard Johnstone and Jason Adam Okazaki have been the director of 6 other Irish companies between them; 1 of which is now closed. Gilead Biopharmaceutics Ireland UC has 2 shareholders.

Company Name:Gilead Biopharmaceutics Ireland UC
Company Status:NORMAL
Company Address:70 Sir John Rogerson's Quay,
Dublin 2
Key Executive:David Richard Johnstone
Company Size:Log-In To View
Established:13/12/1999 (18 years in business).

Key Contact Profile

David Richard Johnstone is a Company Director of Gilead Biopharmaceutics Ireland UC since 2004 and a listed Director of 3 other companies.

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Gilead Biopharmaceutics Ireland UC (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
B2 CHANGE IN SITUATION OF REG OFFICE.16/12/201621/12/2016Join Up
B1 ANNUAL RETURN30/09/201628/10/2016Join Up
AUDITORS REPORT30/09/201628/10/2016Join Up
N3 CHANGE OF COMPANY NAME(NEW ACT REQUIREMENT)26/09/201610/10/2016Join Up
CONSTITUTION26/09/201610/10/2016Join Up
THIS COMPANY HAS 71 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Gilead Biopharmaceutics Ireland UC for Free.

Company Status:Normal
Latest Credit Movement:
Date of Last Movement:23/11/2016
Latest Accounts Filed:28/10/2009
Report Based on Accounts:31/12/2008
Next Set of Accounts Due:30/09/2017
Overdue:No
Credit Score:Free To View

Free Credit Rating

To View the latest Credit Rating or Credit Limit for free on Gilead Biopharmaceutics Ireland UC simply click 'Free Report' below. You can access 1 free credit report per email address.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors

Satisfy due diligence requirments on Gilead Biopharmaceutics Ireland UC in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Gilead Biopharmaceutics Ireland UC and Anti-Money Laundering checks (AML checks) on Gilead Biopharmaceutics Ireland UC

Director:David Richard Johnstone
Director:Regan Glen Shea
Other Directors:Gilead Biopharmaceutics Ireland UC has 3 other Directors.

Ownership Structure

Company Type:ULC - Private Unlimited Company (Licenced Company)
Number of Shareholders:2

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Gilead Biopharmaceutics Ireland UC or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

Shoppers go North for Christmas 2016

22/12/2016

Quarter of Irish shoppers plan to travel North to avail of weaker sterling

Read More »

2016 Is The Year Of The ENTREPRENEUR - Free List Of Live Registrations

10/11/2016

Generate new leads and win clients with a FREE Business List of Live Registrations from Vision-net.

Read More »

Business Research At Its Best From Your Local Library

01/11/2016

Vision-net is now available from your local Library. Library members across the country can now research companies on Vision-net for free from their local library

Read More »

Learn more about the key corporate trends from the first 9 months of 2016

19/10/2016

Vision-net.ie has compiled a guide of the key corporate insolvency, bad debt and start-up trends for the first 9 months of 2016.

Read More »